Your browser doesn't support javascript.
loading
A Case of Sustained Tumor Regression With MP0274, a Novel DARPin Therapeutic Targeting Human Epidermal Growth Factor Receptor 2 Signaling, in Metastatic Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer After Prior Trastuzumab and Pertuzumab.
Fischer, Stefanie; Götze, Thorsten O; Omlin, Aurelius; Baird, Richard D; Dawson, Keith M; Zitt, Christof; Arany, Zita; Tresch, Gaby; Fiedler, Ulrike; Jeger, Simone; Fung, Samson; Legenne, Philippe; Leupin, Nicolas; Schneeweiss, Andreas; Fremd, Carlo.
Afiliação
  • Fischer S; Kantonsspital St Gallen, Klinik für Medizinische Onkologie und Hämatologie, St Gallen, Switzerland.
  • Götze TO; Krankenhaus Nordwest GmbH, Institut für Klinisch-Onkologische Forschung, Frankfurt, Germany.
  • Omlin A; Kantonsspital St Gallen, Klinik für Medizinische Onkologie und Hämatologie, St Gallen, Switzerland.
  • Baird RD; Cancer Research UK Cambridge Centre, Cambridge, United Kingdom.
  • Dawson KM; Molecular Partners AG, Schlieren, Switzerland.
  • Zitt C; Molecular Partners AG, Schlieren, Switzerland.
  • Arany Z; Molecular Partners AG, Schlieren, Switzerland.
  • Tresch G; Molecular Partners AG, Schlieren, Switzerland.
  • Fiedler U; Molecular Partners AG, Schlieren, Switzerland.
  • Jeger S; NBE-Therapeutics AG/Boehringer Ingelheim, Basel, Switzerland.
  • Fung S; Molecular Partners AG, Schlieren, Switzerland.
  • Legenne P; Fung Consulting, Eching, Germany.
  • Leupin N; Molecular Partners AG, Schlieren, Switzerland.
  • Schneeweiss A; Molecular Partners AG, Schlieren, Switzerland.
  • Fremd C; National Center for Tumor Diseases (NCT), Heidelberg University Hospital and German Cancer Research Center, Heidelberg, Germany.
JCO Precis Oncol ; 6: e2200006, 2022 11.
Article em En | MEDLINE | ID: mdl-36331248

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Antineoplásicos Limite: Female / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Antineoplásicos Limite: Female / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article